Tatsuo Kanda

9PUBLICATIONS
10CO-AUTHORS
Medical biotechnology not elsewhere classifiedPredictive and prognostic markersGene mappingHaematologyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 26, 2021
No additive effects of peginterferon on the short-term improvement of liver histology by entecavir monotherapy in chronic hepatitis B patients.

Tatsuo Kanda

|Aug 18, 2019
Prognostic four-gene signature for overall survival in patients with hepatocellular carcinoma.

Tatsuo Kanda, Osamu Yokosuka, Mitsuhiko Moriyama

|Jan 16, 2019
POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33.

Yuki Hitomi, Kazuko Ueno, Yosuke Kawai

|Jul 12, 2018
Hepatitis C virus genotype 4-infection and interferon-free treatment in Egypt.

Tatsuo Kanda, Shunichi Matsuoka, Mitsuhiko Moriyama

|May 23, 2018
Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.

Hiromi Sawai, Nao Nishida, Seik-Soon Khor

|Apr 06, 2018
Early occurrence and recurrence of hepatocellular carcinoma in hepatitis C virus-infected patients after sustained virological response.

Tatsuo Kanda, Shunichi Matsuoka, Mitsuhiko Moriyama

Pageof 2

Frequent Collaborators

1 joint publications

Keisuke Kakisaka

1 joint publications

Shoichiro Tsugane

1 joint publications

Yuki Hitomi

1 joint publications

Shinji Katsushima